Drug Trial News

RSS

Tumor necrosis factor A antagonist use and cancer in patients with rheumatoid arthritis

Patients with rheumatoid arthritis (RA), an autoimmune, inflammatory disease marked by progressive joint and organ damage, face a high risk of developing cancer.

31 Aug 2006

Preventive home visits postpone mortality: a controlled trial with time-limited results

Old people are less likely to die if they receive regular home visits from health professionals.

31 Aug 2006

VIOXX reduces risk of colorectal polyps

A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.

30 Aug 2006

Older twins hold the key to ageing well

Around 300 sets of twins who are 65 or older will take part in one of the largest studies of brain ageing ever undertaken in Australia.

30 Aug 2006

Preoperative Functional MR Imaging localization of language and motor areas

By pinpointing the motor and language areas of the brain with functional magnetic resonance imaging (fMRI), surgeons can target brain tumors more effectively while reducing the risk of damaging important cognitive and motor processes.

30 Aug 2006

Whole-brain T1 mapping in multiple sclerosis

The effects of multiple sclerosis (MS) extend beyond visibly affected areas into large portions of the brain that outwardly appear normal, according to a study appearing in the September issue of Radiology.

30 Aug 2006

Celebrex shown to reduce incidence of potentially pre-malignant colorectal polyps

An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.

30 Aug 2006

Swedish HIV vaccine study shows prmoise

A Swedish HIV vaccine study conducted by researchers at Karolinska Institutet (KI), Karolinska University Hospital and the Swedish Institute for Infectious Disease Control (SMI) has produced surprisingly good results.

30 Aug 2006

Excessive exercise and eating disorders go hand in hand

A study in the United States has found that one of the warning signs of an eating disorder is excessive exercise.

30 Aug 2006

Study aims to lower diabetes risk in youth

As schools across the country reopen their doors this fall, hundreds of sixth graders in 42 middle schools will begin taking part in a study sponsored by the National Institutes of Health (NIH).

30 Aug 2006

Nature changes wording of news release for work that reports method of creating stem cells without destroying embryos

The journal Nature last Friday corrected wording in a news release it had distributed in advance of a study published in the Aug. 24 edition of the journal that describes a technique that could derive human embryonic stem cells without destroying the embryo.

30 Aug 2006

Antiretroviral drug Lopinavir selectively kills HPV-infected cells in lab tests

The protease inhibitor lopinavir - the primary component of Abbott Laboratories' antiretroviral drug Kaletra - selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy.

From The University of Manchester 30 Aug 2006

Obesity might lead to more aggressive ovarian cancer

Obesity might cause an increase in deaths related to ovarian cancer, according to a study published in the Aug. 28 edition of the journal Cancer, the New York Times reports.

30 Aug 2006

Young people are more likely to use condoms with a casual sex partner than with their main partner

The study finds that those with and without regular partners on average have the same amount of unprotected sex.

30 Aug 2006

Cellegy ends phase III microbicide trial in Nigeria

Cellegy Pharmaceuticals on Monday announced that it has ended phase Phase III clinical trials in Nigeria on its microbicide Savvy, the Philadelphia Inquirer reports (Loyd, Philadelphia Inquirer, 8/29).

30 Aug 2006

FDA advisory panels almost always recommend approval for new drugs and devices

Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.

30 Aug 2006